Christopher Hernandez MD

Published on 7/8/2025

Wang B, Stephen SJ, Cyphert EL, Liu C, Hernandez CJ, Vashishth D. Fecal microbiota transplantation in mice improves bone material properties through altered mineral quality. JBMR Plus. 2025 Sep; 9(9):ziaf115. PMID: 40861794.

Published on 5/5/2025

Cyphert EL, Nand S, Franco G, Hajkowski M, Soto L, Lee DM, Ferner MC, Zabin CJ, Blumenthal J, Deck AK, Boyer KE, Burrus LW, Hernandez CJ, Anand A. Combinatorial characterization of bacterial taxa-driven differences in the microbiome of oyster beds. Sustain Microbiol. 2025; 2(2):qvaf006. PMID: 40417391.

Published on 4/10/2025

Liu M, Liu C, Cevallos N, Orbach BN, Hernandez CJ, Fu X, Lee J, Booth SL, Shea MK. Dietary menaquinone-9 supplementation does not influence bone tissue quality or bone mineral density during skeletal development in mice. JBMR Plus. 2025 Jun; 9(6):ziaf059. PMID: 40386291.

Published on 2/12/2025

Zhang W, Harper CE, Lee J, Fu B, Ramsukh M, Hernandez CJ, Chen P. Transporter excess and clustering facilitate adaptor protein shuttling for bacterial efflux. Cell Rep Phys Sci. 2025 Feb 19; 6(2). PMID: 40083904.

Published on 2/2/2025

Liu M, Liu C, Cevallos N, Orbach BN, Hernandez CJ, Fu X, Lee J, Booth SL, Shea MK. Dietary Menaquinone-9 Supplementation Does Not Influence Bone Tissue Quality or Bone Mineral Density in Mice. bioRxiv. 2025 Feb 02. PMID: 39975193.

Published on 11/6/2024

Hernandez CJ, Lim J, Takele R, Escobedo F, Dominique G, Ojeaburu L, Scotland K. Identifying and Evaluating Online Kidney Stone Pain Resources: A Cross-Sectional Study. Cureus. 2024 Nov; 16(11):e73140. PMID: 39650933.

Published on 10/29/2024

Liu C, Cyphert EL, Stephen SJ, Wang B, Morales AL, Nixon JC, Natsoulas NR, Garcia M, Carmona PB, Vill AC, Donnelly E, Brito IL, Vashishth D, Hernandez CJ. Microbiome-induced increases and decreases in bone matrix strength can be initiated after skeletal maturity. J Bone Miner Res. 2024 Oct 29; 39(11):1621-1632. PMID: 39348436.

Published on 9/9/2024

Harrison CN, Mesa R, Talpaz M, Al-Ali HK, Xicoy B, Passamonti F, Palandri F, Benevolo G, Vannucchi AM, Mediavilla C, Iurlo A, Kim I, Rose S, Brown P, Hernandez C, Wang J, Kiladjian JJ. Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Haematol. 2024 Oct; 11(10):e729-e740. PMID: 39265613.

Published on 6/5/2024

Gupta V, Yacoub A, Mesa RA, Harrison CN, Vannucchi AM, Kiladjian JJ, Deeg HJ, Fazal S, Foltz L, Mattison RJ, Miller CB, Parameswaran V, Brown P, Hernandez C, Wang J, Talpaz M. Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial. Leuk Lymphoma. 2024 Sep; 65(9):1314-1324. PMID: 38838026.

Published on 4/9/2024

Lee J, Jha K, Harper CE, Zhang W, Ramsukh M, Bouklas N, Dörr T, Chen P, Hernandez CJ. Determining the Young's Modulus of the Bacterial Cell Envelope. ACS Biomater Sci Eng. 2024 May 13; 10(5):2956-2966. PMID: 38593061.